emerg
sever
viru
infect
last
decad
like
dengu
west
nile
wn
sever
acut
respiratori
syndrom
sar
chikungunya
chik
middl
east
respiratori
syndrom
coronaviru
merscov
ebola
ebo
zika
zik
yellow
fever
yf
rais
question
quick
reliabl
laboratori
diagnost
test
verif
suspect
case
import
question
aris
emerg
infect
like
sourc
rout
transmiss
infect
patient
recommend
safeti
measur
health
care
person
distribut
anim
reservoir
vector
requir
perform
laboratori
diagnosi
investig
patient
infect
often
blood
sampl
taken
analysi
blood
paramet
also
pathogen
detect
mostli
pcr
test
presenc
specif
antibodi
howev
sampl
blood
requir
medic
train
person
compris
risk
patient
well
health
care
person
particular
blood
sampl
patient
highli
infecti
haemorrhag
fever
like
ebola
involv
great
risk
physician
patient
therefor
sampl
noninvas
method
eg
saliva
urin
might
valuabl
altern
investig
diseas
patient
use
saliva
urin
diagnosi
mani
viral
infect
report
howev
often
perform
broad
routin
diagnost
viral
infect
usual
take
day
propag
viru
caus
symptom
clinic
investig
patient
indic
blood
sampl
analys
blood
paramet
belong
routin
procedur
develop
countri
differ
develop
countri
extens
analys
clinic
paramet
perform
routin
due
financi
technic
constraint
even
though
sampl
swap
respiratori
track
common
procedur
influenza
sar
merscov
respiratori
infect
sampl
blood
preval
procedur
recent
emerg
virus
howev
introduct
highli
sensit
nucleic
acid
test
nat
diagnost
also
addit
sampl
like
saliva
andor
urin
includ
diagnost
sampl
collect
advantag
use
noninvas
sampl
like
saliva
dengu
serolog
success
proven
year
ago
cuzzubbo
et
al
discov
dengu
primari
secondari
infect
distinguish
level
igg
saliva
specif
diagnosi
acut
flaviviru
infect
like
dengu
wn
yf
improv
appli
nat
imped
widespread
crossreact
found
serolog
assay
sinc
urin
saliva
noninvas
sampl
part
routin
investig
sampl
procedur
sampl
contain
also
differ
differ
complic
interpret
diagnost
find
therefor
optim
sampl
requir
improv
sampl
stabil
viral
rna
diagnost
materi
help
increas
significantli
diagnost
sensit
analys
use
altern
noninvas
sampl
diagnost
infecti
viral
diseas
like
sar
wn
dengu
merscov
ebola
zika
yf
review
import
saliva
urin
diagnosi
recent
emerg
virus
comparison
convent
blood
sampl
sinc
extens
evalu
differ
sampl
human
patient
often
perform
also
investig
anim
model
vector
consid
therefor
perform
electron
literatur
review
pubm
altern
sampl
sar
wn
dengu
merscov
ebola
zika
yf
review
literatur
urin
saliva
sampl
diagnost
chik
dengu
ebola
wn
zika
yf
sar
mer
perform
use
electron
databas
pubm
period
search
januari
august
appropri
articl
select
accord
abstract
review
reason
diagnost
analysi
sampl
type
use
method
appli
diagnosi
focus
saliva
urin
test
sampl
search
profil
use
review
pubm
chik
exampl
chikungunya
viru
mesh
term
chikungunya
field
viru
field
chikungunya
viru
field
saliva
mesh
term
saliva
field
chikungunya
viru
mesh
term
chikungunya
field
viru
field
chikungunya
viru
field
urin
subhead
urin
field
urin
mesh
term
anoth
refer
consid
analys
prepar
storag
diagnost
sampl
demonstr
tabl
see
addit
file
detail
methodolog
literatur
research
reveal
paper
consid
studi
addit
file
figur
furthermor
public
analys
sampl
process
prepar
includ
analysi
show
put
emphasi
noninvas
sampl
disclos
easi
altern
collect
human
sampl
clinic
routin
investig
present
review
provid
indic
noninvas
sampl
offer
promis
altern
routin
diagnost
well
favour
diagnost
approach
surveil
studi
high
number
sampl
review
provid
overview
usabl
noninvas
sampl
diagnost
emerg
virus
tri
give
recommend
experi
could
help
futur
possibl
outbreak
emerg
virus
epidem
la
reunion
autochthon
outbreak
itali
spread
caribbean
island
decemb
chikungunya
chik
emerg
first
time
central
america
spread
south
america
north
america
typic
clinic
specimen
chikv
blood
serum
plasma
also
urin
saliva
rare
case
csf
tabl
addit
file
tabl
systemat
evalu
chik
infect
mice
cynomolgu
macaqu
reveal
infect
differ
bodi
fluid
like
saliva
urin
vagin
swap
could
confirm
analysi
saliva
sampl
acut
chikv
patient
haemorrhag
manifest
found
contain
viral
rna
infecti
viru
anoth
studi
show
rna
chikungunya
viru
detect
saliva
first
seven
day
infect
lower
efficaci
blood
sampl
also
detect
chikv
genom
rtpcr
urin
success
one
return
travel
valuabl
confirm
posit
serolog
base
experi
viral
infect
analysi
throat
swab
urin
part
recommend
chik
diagnost
common
clinic
specimen
use
dengu
infect
blood
plasma
serum
also
case
csf
breast
milk
tabl
addit
file
tabl
interestingli
twentytwo
select
public
describ
well
progress
use
saliva
urin
non
invas
sampl
base
exist
igg
elisa
serolog
found
igg
level
saliva
could
appli
differenti
dengu
primari
secondari
infect
one
year
later
artimo
de
oliveira
et
al
use
saliva
detect
specif
igm
recent
infect
torr
et
al
found
first
time
evid
denv
rna
saliva
plasma
rtpcr
evalu
saliva
sampl
altern
approach
serolog
diagnosi
igm
igg
iga
investig
complement
systemat
kinet
analysi
infect
also
compris
urin
addit
altern
sampl
sinc
sensit
specif
posit
predict
valu
neg
predict
valu
detect
igg
saliva
high
consid
promis
sampl
type
dengu
diagnost
also
case
report
analys
acut
infect
detect
denv
urin
saliva
rtpcr
well
applic
filterpap
saliva
sampl
prove
use
noninvas
sampl
util
saliva
assay
detect
denvspecif
iga
earli
phase
dengu
infect
show
sensit
dayon
fever
onset
good
correl
iga
level
serum
specif
den
antigen
detect
urin
around
two
third
dengu
fever
den
haemorrhag
fever
hf
use
elisa
follow
excret
urin
import
particularli
patient
develop
df
dhf
indic
protein
leakag
studi
demonstr
strip
assay
less
sensit
urin
compar
elisa
assay
need
adapt
improv
sensit
confirm
later
studi
saito
et
al
show
urin
sampl
could
use
antigen
elisa
case
serum
sampl
limit
poor
resourc
set
studi
perform
use
saliva
urin
sampl
besid
serum
quantit
rtpcr
paramet
igm
igg
dengu
diagnost
cours
diseas
studi
underlin
benefit
saliva
diagnost
tool
use
develop
tropic
countri
like
india
nevertheless
research
encourag
implement
delay
releas
denv
urin
allow
diagnosi
acut
dengu
infect
rtpcr
sequenc
day
respect
serum
sampl
collect
period
neg
denv
promis
result
use
urin
saliva
sampl
diagnost
stimul
investig
denv
rna
stabil
urin
serum
well
establish
novel
diagnost
devic
stack
flow
platform
singlestep
detect
target
antibodi
salivari
fluid
studi
investig
differ
condit
use
urin
saliva
sampl
diagnost
one
studi
focus
storag
condit
sampl
improv
sampl
process
optim
diagnost
use
saliva
andri
et
al
perform
repres
studi
analys
plasma
saliva
urin
patient
appli
variou
molecular
serolog
analys
unfortun
perform
assay
better
upon
use
plasma
sampl
analys
commerci
rapid
diagnost
test
rdt
detect
urin
saliva
sampl
suggest
rdt
kit
higher
specif
limit
sensit
interestingli
dengu
secondari
infect
iga
urin
day
diseas
onset
higher
infect
indic
sever
dengu
therefor
denv
iga
urin
indic
diseas
sever
must
investig
ebola
viru
viral
hemorrhag
fever
mostli
detect
blood
deriv
sampl
whole
blood
plasma
serum
recent
studi
report
ebola
detect
also
bodi
fluid
includ
saliva
urin
sweat
tear
semen
vagin
discharg
well
fece
ammonit
fluid
placenta
breast
milk
tabl
addit
file
tabl
search
altern
sampl
ebola
yield
public
perform
recent
ebola
outbreak
public
found
vhf
virus
like
hanta
hit
marburg
junin
vhf
gener
lassa
crimean
congo
hemorrhag
fever
cchf
rift
valley
fever
rvf
guanarito
novel
bunya
virusth
first
report
date
rvf
viru
detect
saliva
base
experiment
infect
sheep
show
success
viru
isol
saliva
complet
extens
analysi
infect
rodent
main
transmiss
vector
hantaviru
besid
viru
excret
hanta
viru
could
demonstr
sever
organ
lung
kidney
salivari
gland
liver
viru
isol
saliva
urin
fece
one
year
post
inocul
also
intens
investig
import
lassa
case
uk
demonstr
high
viral
load
blood
taken
eleven
day
post
onset
diseas
well
signific
viru
count
urin
day
throat
swab
yield
detect
viru
find
confirm
intens
analysi
acut
lassa
viru
infect
patient
use
urin
addit
sampl
serum
success
investig
viral
rna
pcr
vereta
colleagu
use
urin
urin
sediment
epithelium
identif
acut
hanta
viru
patient
show
hemorrhag
fever
renal
syndrom
hfr
urin
becom
import
sampl
serolog
studi
sinc
antibodi
excret
urin
coincid
period
renal
structur
damag
stop
normal
renal
function
restor
first
success
hantaviru
isol
fatal
hfr
case
use
urin
brain
tissu
confirm
rtpcr
henceforward
urin
use
antigen
genom
detect
well
serolog
experiment
infect
pig
demonstr
pig
host
viral
transmiss
hfr
viru
petterson
et
al
could
demonstr
hantaviru
rna
found
saliva
day
diseas
onset
associ
antihantaviru
iga
hantaviru
rna
saliva
invers
true
detect
rna
antigen
endotheli
cell
within
parotid
gland
hfr
patient
recent
studi
antihantaviru
antibodi
saliva
detect
risk
group
farm
yorkshir
uk
herebi
noninvas
saliva
sampl
confirm
use
hantaviru
surveil
studi
analyz
presenc
hantaviru
previous
unknown
risk
area
also
recent
investig
hanta
viru
persist
wild
rodent
base
analysi
viral
rna
saliva
urin
fece
show
peak
first
month
seroconvers
continu
throughout
month
studi
urin
saliva
noninvas
sampl
also
success
use
analyz
pathogenesi
junin
viru
rodent
vector
respons
viru
transmiss
day
post
infect
surviv
anim
show
viral
dissemin
brain
spleen
kidney
salivari
gland
half
anim
shed
junin
viru
half
neg
infecti
viru
seroconvert
find
success
use
analyz
preval
junin
viru
rodent
popul
endem
area
defin
risk
area
junin
viru
infect
noninvas
sampl
like
urin
use
analysi
guinea
pig
rhesu
macaqu
infect
experi
highli
infecti
deadli
marburg
viru
particular
danger
biosafeti
level
pathogen
sampl
blood
riski
laboratori
infect
possibl
avoid
sampl
urin
guinea
pig
model
persist
shed
marburg
viru
saliva
urin
fece
show
earli
end
incub
period
throughout
diseas
viru
could
found
fece
saliva
virtual
concentr
blood
content
viru
high
increas
end
diseas
similar
approach
use
investig
bat
fecal
urin
sampl
marburg
viru
infect
tourist
visit
cave
uganda
around
liverspleen
tissu
captur
bat
posit
rtpcr
marburg
viru
moreov
viru
detect
differ
tissu
plasma
egyptian
fruit
bat
subcutan
inocul
marburg
viru
limit
result
obtain
appli
mucos
swab
sampl
urin
fecal
sampl
antibodi
ebola
viru
could
found
oral
fluid
agreement
presenc
rna
serum
oral
fluid
rtpcr
observ
moreov
confirm
ebola
case
sampl
includ
saliva
stool
semen
breast
milk
tear
nasal
blood
skin
swab
posit
ebola
cultur
andor
rtpcr
case
ebov
sampl
includ
bodi
fluid
must
handl
appli
recommend
sinc
highli
infectiousth
recent
ebolaviru
outbreak
serra
leon
liberia
und
guinea
death
initi
sever
intens
investig
differ
patient
specimen
like
blood
urin
sweat
saliva
conjunctiv
swap
stool
semen
infecti
viru
becam
major
interest
sinc
transmiss
rout
alway
obviou
previou
experi
moreov
public
health
measur
requir
clear
refer
recov
patient
infecti
anymor
releas
quarantin
excret
ebov
bodi
fluid
infect
recov
patient
creat
great
risk
person
contact
ebola
viru
rna
detect
follow
bodi
fluid
week
sever
month
infect
saliva
conjunctivatear
stool
vagin
fluid
sweat
urin
amniot
fluid
aqueou
humor
cerebrospin
fluid
breast
milk
semen
rais
mani
concern
regard
long
term
transmiss
infecti
viru
caus
recrudesc
outbreak
compar
wholeblood
urin
specimen
analysi
ebola
patient
novel
diagnost
filmarray
rtpcr
show
reason
match
whole
blood
urin
test
stabil
ebola
viru
rna
human
blood
urin
environment
african
condit
show
viral
rna
test
blood
sampl
store
edta
buffer
sensit
viral
rna
urin
seem
less
stabl
compar
blood
sinc
urin
sampl
found
posit
rtpcr
day
compar
blood
least
sinc
cchf
outbreak
turkey
detect
viru
bodi
fluid
receiv
attent
avoid
secondari
infect
rna
cchf
viru
identifi
saliva
urin
patient
respect
confirm
later
studi
detect
cchf
viru
urin
sampl
patient
prolong
viremia
furthermor
nasopharyng
aspir
andor
urin
consid
diagnost
sampl
evalu
multiplex
hybrid
array
detect
variou
infecti
diseas
interestingli
plasmodium
falciparum
identifi
caus
death
case
hemorrhag
fever
like
ill
marburg
hemorrhag
fever
outbreak
angola
also
novel
diagnost
array
base
bead
technolog
detect
multipl
batborn
virus
includ
ebola
nipha
virus
use
urin
wild
bat
australia
bangladesh
surveil
studi
analyz
case
china
hemorrhag
fever
due
novel
bunya
viru
rna
identif
blood
well
urin
throat
fecal
specimen
studi
necessari
investig
signific
noninvas
sampl
analyz
viru
pathogenesi
infect
differ
bodi
fluid
clinic
specimen
use
wnv
detect
blood
deriv
sampl
csf
tabl
addit
file
tabl
sinc
safeti
blood
bank
import
test
blood
sampl
evid
choic
even
though
steel
et
al
found
infecti
wn
sever
organ
brain
heart
spleen
liver
kidney
adren
intestin
pancrea
lung
ovari
bird
took
four
year
tesh
other
publish
investig
urin
sampl
use
pathogenesi
studi
hamster
bird
find
later
confirm
differ
anim
model
like
chipmunk
fox
squirrel
hamster
mice
analyz
wnv
pathogenesi
research
first
report
wn
detect
urin
acut
sever
case
enceph
found
posit
eight
day
symptom
onset
studi
detect
wnv
rna
year
urin
indic
persist
renal
infect
sever
year
confirm
number
studi
demonstr
long
persist
wnv
particularli
patient
wn
fever
compar
patient
wn
neuroinvas
diseas
higher
vireamia
shorter
period
west
nile
fever
meantim
advantag
use
urin
instead
addit
serum
demonstr
mani
investig
could
prove
valu
also
routin
diagnost
also
wnv
could
success
isol
urin
sampl
analyz
sequenc
summari
one
could
state
use
urin
suitabl
altern
diagnost
sampl
compar
serum
list
fact
sheet
nation
intern
organ
paho
cdc
ecdc
studi
need
investig
urin
sampl
use
sourc
surveil
studi
wnv
distribut
analyz
sever
diseas
patient
neuroinvas
andor
kidney
manifest
zika
viru
detect
blood
serum
saliva
urin
well
semen
vagin
discharg
sweat
tear
ammonit
fluid
placenta
breast
milk
tabl
addit
file
tabl
expans
zika
brazil
via
new
caledonia
stimul
develop
diagnost
assay
nat
serolog
analyz
increas
number
case
surveil
studi
zikv
identifi
total
patient
saliva
sampl
blood
detect
zikv
saliva
sampl
increas
molecular
detect
rate
zikv
acut
case
zikv
persist
longer
time
frame
saliva
urin
semen
nevertheless
saliva
sampl
advantag
children
neonat
interestingli
zikv
detect
urin
sampl
even
longer
combin
urin
saliva
besid
serum
great
signific
zikv
diagnost
also
true
rhesu
macaqu
model
use
analyz
plasma
saliva
urin
cerebrospin
fluid
rtpcr
zikv
detect
moreov
rna
zikv
detect
semen
rtpcr
day
appear
symptom
identifi
day
confirm
reusken
et
al
find
consequ
lead
possibl
infect
via
sexual
intercours
document
dortenzio
et
al
high
viral
load
semen
obtain
sampl
collect
day
sever
smaller
bigger
studi
usabl
saliva
urin
besid
blood
sampl
demonstr
zika
viru
diagnost
excret
viral
rna
urin
saliva
observ
day
symptom
onset
higher
viral
load
blood
high
risk
transmiss
patient
bodi
fluid
also
rais
concern
appropri
safeti
measur
health
care
person
discuss
sever
public
yellow
fever
gener
detect
blood
plasma
serum
csf
flavivirus
tabl
addit
file
tabl
although
altern
sampl
demonstr
use
flaviviru
infect
like
urin
saliva
sampl
diagnost
dengu
west
nile
yf
investig
first
report
show
use
urin
sampl
diagnost
advers
event
yf
vaccin
vaccine
develop
sever
side
effect
vaccin
could
clearli
shown
viral
shed
prolong
day
post
vaccin
releas
yf
rna
could
found
urin
day
vaccin
detect
yf
attenu
vaccin
viru
could
demonstr
urin
easili
howev
repres
data
altern
sampl
like
urin
saliva
yf
infect
miss
particular
case
sever
cours
diseas
numer
hemorrhag
bleed
use
noninvas
sampl
would
real
altern
prevent
bodili
injuri
patient
sar
emerg
novemb
obviou
analyz
sampl
respiratori
tract
diagnost
howev
even
first
sar
patient
sampl
besid
blood
nasopharyng
aspir
sampl
like
fece
urin
found
posit
viral
rna
respect
tabl
addit
file
tabl
confirm
analysi
throat
wash
saliva
show
high
viru
load
rna
copi
per
ml
respect
moreov
detect
sar
plasma
sputum
endotrach
aspir
stool
throat
swab
saliva
reveal
signific
differ
type
sampl
sampl
lower
respiratori
tract
test
posit
cheng
et
al
found
death
associ
higher
viru
load
nasopharyng
specimen
obtain
day
onset
symptom
differ
sampl
like
serum
nasopharyng
aspir
npa
throat
swab
nasal
swab
rectal
swab
stool
urin
use
analysi
viral
pathogenesi
cours
diseas
diarrhea
hepat
dysfunct
associ
high
viral
load
npa
urin
associ
abnorm
urinalysi
find
extens
analysi
sar
patient
reveal
presenc
sar
respiratori
specimen
two
week
diseas
onset
stool
rectal
swab
urin
specimen
four
week
throat
nasal
swab
less
signific
npa
specimen
therefor
high
viral
load
npa
major
impact
airborn
transmiss
play
major
role
outbreak
hong
kong
evalu
commerci
pcr
kit
inhous
antigenelisa
qualiti
sar
diagnost
import
task
select
appropri
test
select
sampl
sensit
rtpcr
higher
compar
two
antigenelisa
rna
sarscov
detect
earlier
fecal
specimen
around
patient
urin
sampl
base
find
rtpcr
method
choic
earli
diagnosi
sar
cov
infect
copres
viral
rna
antibodi
plasma
observ
three
week
two
case
addit
sarscov
isol
stool
urin
specimen
longer
week
sinc
detect
sar
viru
possibl
variou
clinic
sampl
npa
throatswab
fecal
cerebrospin
fluid
blood
urin
viral
cultur
rtpcr
clear
signific
recommend
diagnost
sar
base
previou
experi
work
multicentr
collabor
network
requir
appropri
updat
even
though
sar
appear
outbreak
except
two
laboratori
infect
thereaft
bat
like
anim
vector
cov
also
experi
mice
rhesu
macaqu
analyz
viral
pathogenesi
develop
effect
strategi
diagnosi
prevent
therapi
vaccin
design
evalu
sinc
salivari
gland
epitheli
cell
affect
first
target
infect
immun
viru
like
particl
might
elicit
protect
immun
respons
sarscov
gener
mucos
immun
new
vaccin
approach
provid
import
inform
futur
vaccin
design
boost
nearli
public
altern
sampl
within
three
year
demonstr
import
document
public
health
concern
respiratori
diseas
caus
new
corona
viru
cov
addit
file
tabl
public
roughli
categor
follow
case
report
descript
pathogenesi
recommend
investig
diagnost
recommend
analysi
risk
health
care
worker
recommend
patient
manag
control
prevent
includ
treatment
vaccin
develop
select
public
consid
review
bronchoalveolar
lower
respiratori
tract
fluid
highli
posit
merscov
two
identifi
case
urin
sampl
posit
day
stool
sampl
oronas
swab
contain
low
merscov
copi
number
day
respect
viru
detect
blood
begin
outbreak
way
transmiss
rather
unclear
therefor
viru
replic
kidney
potenti
shed
urin
investig
clarifi
differ
transmiss
rout
predict
model
oralfec
andor
oralsaliva
transmiss
rout
merscov
develop
evalu
soon
camel
contribut
anim
host
merscov
infect
got
focu
investig
becam
obviou
also
dromedari
camel
eastern
africa
arabian
peninsula
high
seropreval
merscov
antibodi
surveil
studi
camel
hedgehog
bat
often
noninvas
sampl
like
urin
saliva
fecal
nasal
swap
fecal
swap
camel
milk
use
analyz
merscov
rna
specif
antibodi
summer
confirm
case
mer
fatal
report
republ
korea
caus
nosocomi
outbreak
time
intens
respiratori
viral
shed
merscov
infect
patient
still
major
interest
airborn
transmiss
human
human
droplet
seem
domin
infect
rout
might
introduct
isotherm
amplif
lamp
rpa
detect
emerg
diseas
provid
use
tool
quick
reliabl
diagnost
acut
case
might
lead
immedi
public
health
respons
includ
appropri
safeti
precaut
medic
person
base
experi
respiratori
infect
base
lesson
learn
previou
sar
outbreak
analysi
respiratori
sampl
part
routin
sampl
taken
diagnost
suspect
mer
patient
analysi
use
noninvas
sampl
viru
diagnost
clearli
show
procedur
optim
sampl
strategi
differ
viral
infect
serious
investig
tabl
follow
overview
becam
obviou
newli
emerg
virus
like
chik
merscov
zika
broader
attempt
sampl
strategi
perform
investig
well
known
virus
like
yf
dengu
applic
saliva
sampl
choic
diagnosi
chik
fever
infect
small
children
patient
whose
blood
sampl
difficult
obtain
great
signific
howev
recommendationsfact
sheet
chik
nation
intern
organ
cdc
paho
ecdc
mention
saliva
urin
sampl
suitabl
materi
diagnosi
miss
meaning
studi
evalu
saliva
urin
diagnost
sampl
compar
blood
hope
studi
perform
answer
question
repres
number
chik
patient
futur
use
saliva
urin
diagnosi
acut
dengu
infect
great
import
requir
attent
present
studi
show
use
sampl
diagnost
also
monitor
sever
infect
particular
surveil
studi
andor
investig
small
children
noninvas
approach
use
saliva
urin
laboratori
diagnosi
dengu
case
consid
blood
sampl
difficult
obtain
although
applic
altern
sampl
diagnost
becam
popular
recent
year
studi
improv
necessari
establish
sampl
equal
common
plasma
serum
sampl
commerci
assay
well
appropri
sampl
equip
verifi
diagnost
applic
repres
cohort
cours
diseas
seem
increas
awar
altern
sampl
stimul
studi
dengu
diagnosi
demonstr
recent
public
mention
particular
diagnost
vhf
case
investig
use
noninvas
taken
sampl
high
prioriti
sinc
blood
sampl
patient
highli
riski
often
danger
patient
hemorrhag
symptom
continu
bleed
occur
viru
load
sever
case
vhf
high
bodi
fluid
nat
method
choic
sinc
product
specif
igm
andor
igg
antibodi
take
day
sever
case
patient
even
pass
away
develop
detect
antibodi
reaction
gener
viremia
affect
sever
organ
detect
bodi
fluid
less
sever
case
exact
moment
becom
import
issu
sinc
viremia
remain
day
day
often
patient
sampl
taken
late
success
nat
thu
requir
labori
serolog
test
inhous
assay
risk
fals
posit
reactiv
onset
diseas
also
welldefin
point
time
percept
diseas
might
differ
develop
compar
develop
countri
make
comparison
clinic
symptom
diagnost
find
cours
diseas
even
difficult
although
analysi
differ
bodi
fluid
recent
ebola
viru
outbreak
expand
knowledg
viru
transmiss
via
eye
fluid
semen
tremend
systemat
studi
long
differ
bodi
fluid
contain
viral
rna
andor
infecti
virus
still
miss
recommend
noninvas
sampl
perform
kind
sampl
necessari
stabil
transport
african
environment
condit
still
miss
requir
thoroughli
investig
wnv
infect
use
urin
suitabl
altern
diagnost
sampl
compar
serum
list
fact
sheet
nation
intern
organ
studi
need
investig
urin
sampl
use
sourc
surveil
studi
wnv
distribut
analyz
sever
diseas
patient
neuroinvas
andor
kidney
manifest
emerg
zika
viru
tremend
stimul
investig
use
noninvas
sampl
saliva
urin
diagnost
zika
viru
infect
start
zika
outbreak
french
polynesia
saliva
consid
altern
materi
diagnost
investig
urin
saliva
show
higher
viru
load
compar
blood
make
sampl
suitabl
altern
blood
howev
inform
forward
physician
alreadi
part
paho
recommend
yf
diagnost
one
hope
integr
saliva
urin
altern
sampl
recommend
work
recent
outbreak
help
implement
method
medic
procedur
creat
meaning
result
futur
outbreak
scenario
even
although
sar
seem
disappear
globe
experi
find
differ
diagnost
sampl
use
quick
reliabl
diagnost
care
evalu
sinc
respiratori
infect
rise
seen
year
later
influenza
merscov
outbreak
great
varieti
respiratori
sampl
taken
reflect
list
nomenclatur
found
public
upper
respiratori
specimen
nasal
swab
exud
nose
oronas
swab
pharyng
swab
tracheal
swab
exud
mouth
saliva
sputum
lower
respiratori
specimen
bronchoalveolar
fluid
bronchoalveolar
lavag
recommend
standard
procedur
sampl
handl
respiratori
sampl
help
allow
better
comparison
find
provid
better
prepared
next
respiratori
diseas
outbreak
higher
viru
load
sampl
lower
respiratori
tract
suitabl
diagnost
howev
sampl
bronchoalveolarlavag
fluid
also
invas
requir
experienc
physician
hold
certain
risk
nosocomi
infect
aerosol
noninvas
sampl
like
urin
nasal
pharyng
tracheal
rectal
swab
includ
diagnost
analysi
analyz
pathogenesi
kinet
viru
releas
differ
bodi
fluid
like
sar
standard
procedur
sampl
handl
respiratori
sampl
help
allow
better
comparison
find
provid
better
prepared
futur
respiratori
diseas
outbreak
present
review
clearli
show
still
need
perform
dilig
studi
analyz
noninvas
patient
sampl
comparison
blood
serum
sampl
use
routin
diagnost
emerg
viral
diseas
diseas
like
respiratori
infect
sampl
nasal
swap
saliva
part
routin
sampl
viral
infect
blood
serum
seem
predomin
type
sampl
use
laboratori
diagnosi
particular
disappoint
noninvas
sampl
offer
real
altern
avoid
addit
risk
patient
medic
person
patient
suspect
infect
vhf
usual
high
viru
load
therefor
analysi
saliva
urin
routin
perform
parallel
investig
blood
sampl
base
solid
databas
possibl
determin
appropri
sampl
viral
diagnosi
get
implement
routin
diagnost
procedur
diagnost
laboratori
physician
gain
knowledg
altern
sampl
consid
analyz
acut
convalesc
viral
infect
even
though
nat
sensit
diagnost
tool
best
point
time
cours
diseas
togeth
optim
sampl
sampl
storag
sampl
prepar
essenti
get
optim
result
laboratori
diagnosi
patient
present
moder
mild
diseas
viremia
mostli
short
last
day
patient
posit
nat
sometim
difficult
achiev
neg
find
predict
valu
sinc
viru
titer
might
detect
limit
sampl
storag
sampl
prepar
optim
case
noninvas
sampl
saliva
urin
although
viru
disappear
blood
viru
genom
still
detect
urin
consequ
clearanc
process
found
yellow
fever
vaccine
zika
contrast
find
high
viral
load
patient
develop
sever
diseas
sometim
gener
infect
affect
sever
organ
particular
patient
detect
pathogen
viru
nat
difficult
analyz
differ
type
sampl
often
viral
load
also
reflect
sever
diseas
use
prognost
marker
progress
diseas
patient
exactli
patient
noninvas
sampl
less
stress
frequent
bleed
perform
current
procedur
becom
even
import
point
care
diagnost
allow
frequent
monitor
infect
paramet
diseas
patient
futur
recent
emerg
chik
zika
south
america
analysi
throat
swap
saliva
urin
sampl
alreadi
analyz
usabl
diagnost
howev
find
base
case
studi
small
studi
requir
systemat
approach
prefer
perform
systemat
analysi
differ
invas
sampl
blood
bronchoalveolar
lavag
noninvas
sampl
saliva
urin
etc
diagnost
valu
use
differ
diagnost
method
patient
acut
convalesc
diseas
new
infect
emerg
also
impli
procedur
take
sampl
somehow
standard
becam
obviou
larg
number
term
upper
lower
respiratori
sampl
like
reflect
great
varieti
sampl
taken
make
compar
diagnost
find
present
differ
studi
difficult
address
problem
clear
recommend
sampl
procedur
would
help
overcom
imponder
furthermor
method
storag
sampl
regard
temperatur
stabil
need
work
allow
optim
transport
prepar
diagnost
sampl
exampl
special
sampl
tube
stabil
avail
saliva
dnagard
saliva
biomatrica
usa
urin
vacuett
urin
ccm
tube
greiner
bioon
germani
urin
monovett
sarstedt
germani
help
preserv
integr
sampl
room
temperatur
sampl
prepar
urin
saliva
could
also
challeng
especi
molecular
diagnost
therefor
import
optim
protocol
use
clinic
sampl
rather
spike
mocksampl
person
experi
show
optim
sampl
prepar
method
real
clinic
sampl
effici
spike
mock
sampl
increas
number
public
consid
altern
sampl
diagnost
recent
outbreak
merscov
chik
ebola
zika
promis
howev
systemat
studi
rare
infecti
diseas
outbreak
like
recent
yellow
fever
angola
noninvas
sampl
diagnost
still
uncommon
requir
investig
diseas
like
yellow
fever
noninvas
sampl
like
urin
saliva
might
practic
altern
sinc
first
index
patient
detect
often
late
blood
neg
nat
patient
mild
diseas
patient
sever
diseas
difficult
take
blood
hemorrhag
clinic
pictur
noninvas
sampl
might
also
great
altern
investig
children
patient
collect
blood
sampl
difficult
also
larg
surveil
studi
noninvas
sampl
like
saliva
andor
urin
could
perform
without
medic
person
collect
blood
howev
usabl
sampl
serolog
nat
evalu
comparison
convent
use
sera
therefor
necessari
introduc
noninvas
sampl
strategi
recommend
done
yellow
fever
laboratori
diagnost
algorithm
work
epidem
nonepidem
countri
africa
yf
outbreak
angola
expert
team
sinc
investig
could
perform
outbreak
situat
prepar
scheme
evalu
sampl
respiratori
well
infecti
diseas
includ
process
laboratori
diagnost
highli
recommend
structur
approach
help
improv
diagnost
emerg
infecti
diseas
significantli
new
diagnost
method
platform
develop
continu
requir
effect
evalu
real
condit
confirm
clinic
diagnosi
correct
laboratori
diagnosi
essenti
step
patient
treatment
handl
particular
new
andor
emerg
diseas
condit
best
sampl
regard
time
sourc
blood
serum
saliva
urin
etc
often
known
sinc
everi
diseas
cours
symptom
affect
organ
optim
sampl
schema
might
chang
requir
differ
strategi
regard
sampl
prepar
process
earli
phase
diseas
symptom
appear
often
viral
pathogen
could
detect
nucleic
acid
test
blood
bodi
fluid
later
phase
antibodi
detect
serum
present
articl
analyz
scientif
public
diagnost
approach
dengu
west
nile
sar
chikungunya
merscov
ebola
zika
yellow
fever
regard
relev
use
altern
sampl
like
saliva
urin
versatil
viru
diagnost
use
noninvas
sampl
offer
suitabl
altern
improv
diagnost
perform
significantli
reduc
risk
medic
person
patient
routin
diagnost
outbreak
situat
advantag
use
noninvas
sampl
diagnost
serious
analyz
investig
implement
routin
diagnost
